Decoy Therapeutics Achieves Nasdaq Compliance After Minimum Bid Price Requirement#USA#NASDAQ#Cambridge,_Massachusetts#Decoy_Therapeutics#Minimum_Bid
Decoy Therapeutics Achieves Nasdaq Compliance After Minimum Bid Price Requirement
Decoy Therapeutics, Inc. has successfully regained compliance with Nasdaq's Minimum Bid Price Requirement, ensuring its continued listing on the exchange.
third-news.com
April 2, 2026 at 2:10 PM
Decoy Therapeutics Achieves Nasdaq Compliance After Minimum Bid Price Requirement#USA#NASDAQ#Cambridge,_Massachusetts#Decoy_Therapeutics#Minimum_Bid